Skip to main content
African Journal of Infectious Diseases logoLink to African Journal of Infectious Diseases
. 2022 Dec 22;17(1):27–44. doi: 10.21010/Ajidv17i1.3

IN VITRO AND IN SILICO ANTIBACTERIAL ACTIVITIES OF SYZGIUM AROMATICUM ESSENTIAL OIL AGAINST BACTERIA ASSOCIATED WITH OTITIS MEDIA IN CHILDREN

OBUOTOR Tolulope Mobolaji 1,*, ADEYANJU Folasade Oluwademilade 1, KOLAWOLE Amos Oyebisi 1, IDOWU Gbohunmi Paul 1, OLUWAMUYIWA Fesobi Andrew 1, AFOLABI Felix Olaide 1
PMCID: PMC9885023  PMID: 36756486

Abstract

Background:

This study investigated the efficacy of the essential oil (EO) of Syzgium aromaticum L. (clove) on the bacteria associated with otitis media.

Materials and Methods:

Ear swab samples were collected and bacteria isolated were identified using morphological and biochemical procedures. Essential oil was extracted from the dried flower buds using the hydro-distillation method while physicochemical and phytochemical analysis was done on the oil. Antibiotic susceptibility test and agar well diffusion was used to determine the susceptibility of the isolates to the EO. In – silico analysis was conducted to determine the drugable compound in the EO.

Results:

Phytochemical analysis of the oil indicated the presence of flavonoids, sterols, phenols, carbohydrates and alkaloids. Physicochemical test of the EO exhibited the presence of eugenol (80.98%) as the most abundant phytocompound. Percentage occurrence of the bacterial isolates are as follows; Proteus mirabilis (31.25%), Staphylococcus aureus (25%), Pseudomonas aeruginosa (18.25%), Proteus vulgaris (3.12%), Moraxella catarrhalis (12.5%), Klebsiella pneumoniae (3.12%) and Staphylococcus epidermidis (6.25%). Zones of inhibition were within the range of 11.5±0.71mm-23.0±2.83mm. In silico studies demonstrated that 16 out of 38 compounds identified passed the ADMET analysis. Various compounds had different binding energies, such as linalool, carvacrol for S. aureus (2NOJ), gamma-eudesmol, eudesmol for Proteus mirabilis (6H2L), eucalyptol, gamma-eudesmol and eudesmol for Proteus vulgaris (4MCX) and Staphylococcus epidermidis (4HBL).

Conclusion:

This study shows the potency of clove EO as an antibacterial agent and its component as potential lead molecules in drug development and design to combat multi – drug resistance.

Keywords: Otitis media, Clove, Antibacterial, Essential oil, MIC, In silico

Introduction

Otitis media (OM) refers to a group of complex infectious and inflammatory diseases affecting the middle ear (Dickson, 2014). This occurs when the middle ear drum and the inner ear, including the Eustachian tube becomes inflamed (Arroll, 2005) and it is a common problem worldwide (Cripps and Kyd, 2003). Egbe et al., (2010) reported that children less than 5 years are more susceptible to otitis media infection and this is due to their shorter and more horizontal Eustachian tube. Children also have lower immunity compared to adults and bacteria tend to attach to the epithelial cells of children than in adults. OM may be presented in different clinical forms including “Acute otitis media (AOM)”, “Otitis media with effusion (OME)” and “Chronic suppurative otitis media (CSOM)”. Sierra et al., 2011 opined that the most common cause of OM is the bacterial infection of the middle ear. AOM is predominantly caused by Streptococcus pneumoniae, Heamophilus influenza and Moraxella catarrhalis (Qureishi et al., 2014). However, Pseudomonas aeruginosa and Staphyloccocus aureus are the most common aerobic microbial isolates in patients with CSOM, followed by Proteus vulgaris and Klebsiella pneumoniae (Sattar et al., 2012; Aduda et al., 2013; Prakash et al., 2013).

Otitis media when not treated properly or paid attention to can lead to several conditions ranging from mild to fatal. Most severe complications are infratemporal (such as mastoiditis) while others are intracranial (mainly intracranial abscess and meningitis) which ultimately may lead to brain damage or death. Due to the alarming increase in the incidence of antibiotic-resistant microorganisms as a result of the incessant use or abuse of antibiotics, there is a need for an alternative therapy to antibiotics which is cost effective and will help reduce exposure to high dosage levels of antibiotics so as to minimize side effects. The increase in the emergence of antibiotic-resistant pathogens (Westh et al., 2004) has called for the need to carry out research on safer phytomedicines and biologically active compounds with acceptable therapeutic index for the development of novel drugs. Traditional uses of plants have led to investigating their bioactive compounds, which have resulted in the detection of a significant number of therapeutic properties (Sharma et al., 2010).

Essential oils (EOs) which are complex mixtures of volatile compounds produced by plants are characterized by a strong odor and are formed as secondary metabolites (Bakkali et al., 2008). Tiwari et al., (2009) opined that plants produce an array of secondary metabolites that can be found in the edible, medicinal, and herbal plants and their derived essential oils (EOs). These secondary metabolites possess various benefits including antimicrobial properties against pathogenic and spoilage microbes. EOs and other plant extracts have been screened as potential sources of new antimicrobial compounds, alternatively to current antibiotics/disinfectants; or as agents used to promote food conservation (Kon and Rai, 2012; Rios and Recio, 2005; Seow et al., 2014).

Cloves (Syzygium aromaticum, syn. Eugenia aromaticum or Eugenia caryophyllata) are the aromatic dried flower buds of a tree in the family Myrtaceae (Chaieb et al., 2007). It is commonly known as Konafuru in Yoruba language and is very common in the Northern part of Nigeria, West Africa. Cloves are used as a carminative, to increase hydrochloric acid in the stomach and to improve peristalsis (Phyllis and James, 2000). It is also used in dentistry where the essential oil of clove is used as anadyne for dental emergencies (Prashar et al., 2006). Clove buds and their essential oils have been associated with antimicrobial and antioxidant properties (Fu et al., 2007). The essential oil extracted from the dried flower buds of cloves is used for acne, warts, scars and parasites. Research has shown that clove oil is an effective mosquito repellent (Trongtokit et al., 2005). The clove oil is also used as a topical application to relieve pain and to promote healing and also finds use in the fragrance and flavouring industries (Chaieb et al., 2007a). However, clove oil is toxic to human cells (Prashar et al., 2006). Saeed and Tariq (2008) reported that “the lethal oral dose is 3.752 g/Kg body weight” and if ingested or injected in sufficient quantity, it can cause life threatening complications, including Acute Respiratory Distress Syndrome, Fulminant Hepatic Failure and Central Nervous System disorder. The strong antioxidant activity of Clove and Eugenol can be comparable to the activities of the Butylated hydroxyl anisole (BHA) and Pyrogallol (Dorman and Dean, 2000).

Drug-discovery research has incorporated a wealth of molecular modeling methods via the integration of computational and experimental strategies for the identification and development of novel therapeutic compounds (Leonardo et al., 2015). In silico studies are useful in predicting the orientation and binding affinity of ligands at the active site of a receptor target (Lopez-Vallejo et al., 2011).Hence the aim of this study is to determine the antibacterial effects of the essential oil of Syzgium aromaticum on both Gram positive and Gram negative multi-drug resistant bacteria isolated from children with otitis media using in silico and in vitro approach.

Materials and Methods

Ethical Approval

Ethical approval was obtained at the Health Research and Ethics Committee of Ogun State Hospital, Ijaiye, Abeokuta, Nigeria, with approval number: SHA/RES/VOI.2/167 on the 6th of April, 2017. Parental consent was also obtained from parents of each patient whose sample was collected.

Collection of samples

Ear swab samples were obtained from 120 children between the age range of 0-5 attending Ogun State Hospital, Ijaiye, Abeokuta, Nigeria and having presented with otitis media. The ear swab samples were immediately transported using buffered peptone water as transport medium to the laboratory for further isolation. Dried flower buds of Syzgium aromaticum were purchased and prepared for extraction.

Extraction of oils from the plants

Essential oils of clove were obtained by hydrodistillation using a vertical hydrodistillation unit (Amel et al., 2015). This was done using the Clavenger’s apparatus (which comprises of the heating mantle, round bottom flask (3000mls), condenser and the separating funnel). During hydrodistillation, the clove buds were heated to boil in the round bottom flask at temperature of 50°C. The essential oils were trapped in the condenser, pipette and dried over anhydrous sodium sulphate and stored in an amber bottle in the refrigerator at 4°C.

Isolation and Identification of Bacteria

The characterization and identification of isolates was based on macroscopic morphology, microscopic morphology and several biochemical tests.

Antibacterial Assay

Antibiotic Susceptibility testing using disc diffusion method

Susceptibility to antibiotics was assessed using the Kirby-Bauer disc diffusion technique. The results were interpreted according to Clinical and Laboratory Standards Institute (CLSI) (CLSI, 2010). The panel of antibiotics used include: (Tetracycline, Amikacin, Gentamycin, Nalidixic acid, Amoxicillin/Clavulanic acid, Trimethoprime/Sulfomethoxazole, Ciprofloxacin, Chloramphenicol, Ampicillin, Cefoxitin). The suspension of the test organism in nutrient broth was matched with 0.5 McFarland turbidity standards to give a concentration of 1.0 x 108 CFU/ml; while the inoculated plates were incubated at 35°C for 18 – 24 hours. The degree of susceptibility of the bacterial isolates to each antibiotic was determined.

Sensitivity testing of the essential oils on the bacterial isolates

The susceptibility of microorganisms to the essential oils of Syzgium aromaticum was determined using agar well diffusion method as described by Gupta et al., (2008) and Ajayi et al., (2008). This was done in duplicates. The zone of inhibition on each plate was examined and measured in millimeters.

Determination of Minimum Inhibitory Concentrations (MIC) and Minimum Bactericidal Concentrations of the Essential oils on bacterial isolates

The method used to determine the inhibitory activity of clove essential oil was similar to that as described by Adukwu et al (2012) and Akinpelu and Onakoya, (2006) with a few modifications. This assay was done to determine the lowest concentration of the oil that will inhibit microbial growth. Two-fold dilutions of each essential oil was prepared to give concentrations range of 0.003% - 100% (v/v) with methanol as solvent. After which 2ml of the different concentrations was added to 18ml pre-sterilized molten nutrient agar. The molten nutrient agar was poured into sterile Petri dishes and allowed to set. The surface of the media was allowed to dry before streaking with the 18 h old standardized bacteria culture. The plates were later incubated at 37°C for 72 h after which they were examined for the presence or absence of growth. The MIC value was taken as the lowest concentration that prevented the growth of the bacteria.

From the result of the MIC, plates that showed no growth were sub-cultured onto sterile nutrient agar plates and incubated for 48 hours for bactericidal activity. The least concentration that did not show any growth on the incubated nutrient agar plates is the MBC.

Determination of Rate of Kill

The killing rate of clove essential oil on Klebsiella pneumoniae and Staphylococccus aureus was done using the protocol as described by Odenholt et al., (2001) and Obuotor et al., (2021).

Determination of Nucleotide Leakage from test organisms by the essential oil of Syzgium aromaticum

The method as described by Akinpelu et al., 2016 was used to determine the leakage of the nucleotides from the test cells. Cells of Staphylococcus aureus and Klebsiella pneumoniae from 18-hour old nutrient broth culture were separately washed with 0.9% (w/v) normal saline. Standardized washed suspension of the test organisms (inoculum size approximately 108 cells) were treated with various concentrations of the fractions and placed in the centrifuge at 10,000 rpm for 10 minutes. The optical density of the supernatant was thereafter detected at 260 nm wavelength using a spectrophotometer. Standardized organism treated with methanol (solvent) only was used as control.

Determination of Protein Leakage from the test organism by the essential oil of Syzgium aromaticum

Cells of Klebsiella pneumoniae and Staphylococcus aureus that have been incubated for 24hours in nutrient broth were separately washed in 0.9%w/v normal saline. The washed suspension of bacterial cells (inoculums size approximately 108 cells 0.5 McFarland standards) was treated with various concentrations of the fraction relative to MICs at various time intervals of 90 minutes. Each suspension was then centrifuged at 7000rpm and supernatant collected was assayed for protein using Bradford (1976) method. In assaying for protein, 0.4mL Bradford reagent was added to 1.6mL sample (0.2mL supernatant plus 1.4mL sterile distilled water) to make up 2mL total volume. Optical Density (OD) of the resulting solution was thereafter taken at 595nm after 5mins. The OD of each of the samples calculated from the equation of the best linear regression line obtained from the graph of bovine serum albumin (BSA) standard curve. Standardized organism treated with methanol (the solvent) only was used as control.

In vitro evaluation of the clove EO and ciprofloxacin

The effects of the essential oil of Syzgium aromaticum in combination with ciprofloxacin against Staphylococcus aureus and Klebsiella pneumoniae were evaluated using the “Overlay Inoculum Susceptibility Disc method” as described by Okore, (2010) with modifications. Pre – sterilized nutrient agar was mixed with the MIC x 1 value of the essential oil of Syzgium aromaticum and poured into sterile clean Petri dish as the base agar and allowed to solidify after which about 2 ml of molten nutrient agar was inoculated with the test organism and shaken gently to ensure uniformity of the cells in the medium. The inoculated medium was then poured on the surface of the base agar to form a thin uniform layer, the overlay inoculum agar, the antibiotic disc (ciprofloxacin (oxoid)) was placed on the agar medium at the center of the solidified agar plates. Two control plates were prepared. Control A contained sterile nutrient agar with the overlay inoculum agar and the antibiotic disc, while control B contained the base agar (without antibiotics) and the overlay inoculum. The three plates in the set were left at room temperature for 1 h to allow for pre-diffusion, and then incubated at 37°C for 24 h. The zone of inhibition formed on the test plates was used to determine the combined effect of the two antibiotics, by comparing it with the result in control B. Synergism is obtained when the diameter of the zone of inhibition in the test plate is greater than that in + control (Ciprofloxacin) by at least 19%; lower than 19% indicates additivity, equal to control B indicates indifference; when it is less than control B, there is antagonism.

% increase was calculated using the formula;

graphic file with name AJID-17-27-g001.jpg

Phytochemical screening of the essential oils

Clove essential oil was subjected to phytochemical screening using the method as described by Kalaivani and Vidhya, (2014). This method was used to test for saponins, tannins, terpenoids, glycosides, alkaloids, flavonoids and reducing sugars.

Antioxidant activity of the essential oils

Radical Scavenging ability

The “radical scavenging” ability of the oil was determined using the stable radical DPPH (2,2-diphenyl-1-picrylhydrazyl hydrate) as described by Brand-Williams et al., (1995). The reaction of DPPH with an antioxidant compound which can donate hydrogen, leads to its reduction (Blois, 1958). The change in colour from deep violet to light yellow was measured using a spectrophotometer at 517nm.

Determination of Total Antioxidant Capacity

This method is based on the reduction of Molybdenum (VI) to Molybdenum (V) by the extract and the subsequent formation of a green phosphate/Molybdenum (V) complex at an acidic pH (Prieto et al., 1999).

Determination of Ferric Reducing Antioxidant Power (FRAP)

The FRAP assay was carried out according to the method described by Benzie and Strain (1999) which is based on “the reduction of ferric – tripyridyltriazine complex to its blue ferrous coloured form” due to electron transfer in the presence of antioxidant.

Metabolite profiling with GCMS Analysis

The Physicochemical properties of Syzgium aromaticum was identified using “Gas Chromatography Mass Spectrometry (GC-MS) analyzer (Shimadzu GC-MS-QP 2010 Ultra)”. SLB-5ms Column fused with silica capillary 0.20mm X 30.0m with film thickness 0.20μm was used for this purpose. The oil was introduced into the equipment and varying components of the oil with their chemical properties were detected at different peaks.

Drug Metabolism and Pharmacokinetics

ADMET studies

The ADMET (absorption, distribution, metabolism, elimination, and toxicity) studies of compounds obtained from GC – MS analysis were carried out using “pkCSM tool (http://biosig.unimelb.edu.au/pkcsm/prediction)” and Swiss ADME (Daina et al. 2017; Pires et al. 2015). Evaluation of their physicochemical properties was first done to decide the Pharmaceutical Active Ingredients (PAIs) utilizing the “Lipinski rule of five” (Molecular weight, logarithms of partial coefficient, hydrogen bond donor (HBD) and hydrogen bond acceptor (HBA)) (Lipinski et al. 1997). Thereafter, the “canonical SMILES” for the molecular structure were acquired from “PubChem” (https://bar chem.ncbi.nlm.nih.gov). The results obtained from this were screened for pharmacokinetic properties.

Ligand preparation

The SDF designs of the ligands were recovered from the “PubChem information base (www.pubchem.ncbi.nlm.nih.gov)” (Kim et al. 2019). The ligands were converted to .pdb format using the “PYMOL atomic illustrations framework (1.7.4.5 Edu)” (DeLano 2002).The ligand atoms were thereafter completely converted to the dockable .pdbqt format using the “Autodock vina program”

Enzyme preparation

The crystal structure of the enzymes of the test organisms (7BYE of Klebsiella pneumoniae, 4HBL of Staphylococcus epidermidis, 3PR7 of Moraxella cattarhalis, 4MCX of Proteus vulgaris. 6SPD of Pseudomonas aeruginosa, 6H2L of Proteus mirabilis and 2NOJ of Staphylococcus aureus) were downloaded from the “protein data bank (www.rcsb.org)”. The crystals were prepared using the method described by Berman et al., (2000) and the enzyme was subsequently saved into .pdbqt format in preparation for molecular docking.

Molecular docking

The protocol of Trott and Olson (2010) was employed in the molecular docking of the ligands with the enzymes from the test organisms. The free binding (∆G bind) was calculated using the protocol as reported by Isa et al. (2020). The binding energies of each compounds were identified and further graphical analysis was obtained using “Discovery Studio Visualizer, BIOVIA, 2016”.

Results

Prevalence of organisms implicated in Otitis Media

The prevalence of the organisms isolated from Otitis media ear swab samples as shown in Figure 1 shows that Proteus mirabilis had the highest occurrence of 31.25% while Proteus vulgaris and Klebsiella pneumonia had the lowest occurrence of 3.13%. Staphyloccoccus aureus, Pseudomonas aeruginosa, Moraxella catarrhalis and Staphylococcus epidermidis had occurrences of 25%, 18.75%, 12.5% and 6.25% respectively.

Figure 1.

Figure 1

Frequency of isolated organisms from ear swab samples

Characteristics of the Essential oils obtained from Syzgium aromaticum

The oil obtained from Syzgium aromaticum was a colourless, dense liquid with a sharp odour and a percentage yield of 4%.

Sensitivity testing of antibiotic disc on bacterial isolates

The antibiotic sensitivity testing on bacterial isolates results are shown in Table 1. It was observed that Pseudomonas aeruginosa and Moraxella cattarhalis were both resistant to 7 out of the 10 antibiotics used, followed by Klebsiella pneumoniae and Proteus vulgaris which were resistant to 6 antibiotics. Staphylococcus aureus and Proteus mirabilis were susceptible to 6 antibiotics in contrast to the other bacterial isolates.

Table 1.

Antibiotic disc sensitivity testing on bacterial isolates (in mm)

Isolates FOX (mm) CN (mm) CIP (mm) AMC (mm) SXT (mm) NA (mm) AMP (mm) C (mm) AMK (mm) TET (mm)
Klesiella pneumonia 12±1.4 23.5±0.7 26±0 15.5±0.7 22±1.4 21.5±0.7 11.5±2.1 6±0 21.5±0.7 6±0
Staphylococcus epidermidis 26±0 30±0 12.5±0.7 33±2.8 7.5±2.1 6±0 32.5±0.7 31±1.4 23±0 13±0
Pseudomonas aeruginosa 6±0 23.5±0.7 28±1.4 6±0 6±0 11.5±0.7 6±0 14±0 21±1.4 11.5±0.7
Proteus vulgaris 24±0 24±0 18.5±2.1 8±0 6±0 22.5±0.7 6±0 7±0 23±0 6±0
Proteus mirabilis 25±0 6±0 18±0 27.5±0.7 17±1.4 20.5±3.5 19.5±0.7 18.5±0.7 6±0 7±0
Moraxella catarrhalis 7±0 8±1.4 31±1.4 35±1.4 6±0 6±0 25±0.7 13.5±2.1 11.5±0.7 19.5±0.7
Staphylococcus aureus 28.5±2.1 28.5±0.7 25.5±0.7 35.5±0.7 6±0 12.5±0.7 30.5±0.7 19.5±2.1 28±0 27.5±0.7

Key: FOX- Cefoxitin (30μg); CN- Gentamycin (120μg); CIP- Ciprofloxacin (5μg); AMC- Amoxicillin/clavulanic acid (30μg); NA- Nalidixic acid (30μg); AMP- Ampicillin (10μg); C- Chloramphenicol (30μg); AMK- Amikacin (30μg); TET- Tetracycline (30μg); SXT- Sulfomethoxazole/Trimethoprin (25μg).

Antibacterial activities of the essential oil of Syzgium aromaticum against bacterial isolates.

The antibacterial activities of the essential oil of Syzgium aromaticum, against bacteria isolated in this study, is as shown in Figure 2. All of the bacterial isolates were susceptible to the essential oil of Syzgium aromaticum with Staphylococcus aureus having the highest zone of inhibition of 23.0 ± 2.8 and Pseudomonas aeruginosa having the lowest zone of inhibition of 11.5 ± 0.7.

Figure 2.

Figure 2

Antibacterial activities exhibited by the essential oil of Clove.

Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of Syzgium aromaticum essential oil against test isolates.

The Minimum Inhibitory Concentration and Minimum Bactericidal Concentration exhibited by the essential oil against the bacterial isolates are as shown in Table 2. The MIC exhibited by the essential oil of Syzgium aromaticum ranged between 0.78%v/v and 3.13%v/v while MBC ranged 0.78%v/v and 1.56%v/v.

Table 2.

The Minimum Inhibitory Concentrations and Minimum Bactericidal Concentrations exhibited by the essential oils of Clove.

S/N Isolates MIC (%v/v) MBC (%v/v)
1 Klebsiella pneumoniae 0.78 0.78
2 Staphylococcus epidermidis 1.56 3.13
3 Pseudomonas aeruginosa 1.56 1.56
4 Proteus vulgaris 0.78 0.78
5 Proteus mirabilis 1.56 3.13
6 Moraxella catarrhalis 3.13 3.13
7 Staphylococcus aureus 1.56 1.56

Killing rate of the essential oil of Syzgium aromaticum on Staphylococcus aureus and Klebsiella pneumoniae

The killing rate exhibited by the essential oil of Syzgium aromaticum at 1 x MIC and 2 x MIC as shown in Figure 3 shows that as the time of exposure increases, there is an incessant decrease of cell population. For Staphylococcus aureus (Figure 3a) at MIC x 1, the colony forming units (cfu) counted at 0 minute was 1 x 108 cfu/ml which then decreases progressively to 2 x 103cfu/ml at 90 minutes. Also, at MIC x 2, 9.3 x 106cfu/ml was counted at 0 minutes and at 70 minutes, there were no colony forming units observed. In addition, for Klebsiella pneumoniae (Figure 3b) at MIC x 1, the colony forming units counted at 0 minutes was 4.5 x 107cfu/ml which also progressively decreases to no colony forming units observed at the 70-minute time exposure. Similarly, at MIC x 2 a total of 8.4 x 105cfu/ml was counted at 0 minute following which a rapid decrease leading to no colony forming units was observed at the 60 minute time exposure.

Figure 3.

Figure 3

Time kill kinetics of clove essential oil against Staphylococcus aureus (Fig 3a) and Klebsiella pneumoniae (Fig 3b).

Mechanism of action of the essential oil of Syzgium aromaticum

Nucleotide leakage as a function of mode of action indicates that the rate of leakage increases as the exposure increases. An increase in the absorbance values of Staphylococcus aureus at MIC x 1 and MIC x 2 is shown in Figure 4a meanwhile the control did not exhibit any significant change in the absorbance values. Figure 4b also shows a rise in the absorbance values of Klebsiella pneumoniae at MIC x 1 and MIC x 2.

Figure 4.

Figure 4

Nucleotide leakage of cells of Staphylococcus aureus (a) and Klebsiella pneumonia (b).

Furthermore, the protein leakage per time interval in Staphylococcus aureus as shown in Figure 5a depicts a steady increase in protein leakage concentration as the time of exposure increases. For MIC x 1 at 0 minute, 10.7μg/ml was recorded and this increased to 23.5μg/ml at 90 minutes while for MIC x 2 there was an increase from 15.6μg/ml at 0 minute to 47.2μg/ml at 90 minutes. Also for Klebsiella pneumoniae as shown in Figure 5b, at 0 minute for MIC x 1 and MIC x 2 the values of 2μg/ml and 13.4μg/ml were recorded respectively while at 90 minutes for MIC x 1 and MIC x 2 the values of 25.8μg/ml and 51.7μg/ml were recorded respectively. Controls for both organisms did not show any significant change in concentration.

Figure 5.

Figure 5

Rate of protein leakage from Staphylococcus aureus (a) and Klebsiella pneumonia (b)

The effect of the combination of the essential oil of Syzgium aromaticum with ciprofloxacin on bacteria isolates.

The impact of the combination of the essential oil of Syzgium aromaticum with the commercial antibiotic Ciprofloxacin (Oxoid) is shown in Table 3.

Table 3.

The effect of the combination of the essential oil of Syzgium aromaticum with ciprofloxacin on bacteria isolates.

Diameter zone of inhibition (mm)
Organisms Test Ciprofloxacin %increase Effect
Staphylococcus aureus 31 32 - Antagonism
Proteus vulgaris 28 18 55.6% Synergism
Proteus mirabilis 22 20 10% Additivity
Pseudomonas aeruginosa 33 39 - Antagonism
Klebsiella pneumonia 58 41 41.5% Synergism
Moraxella catarrhalis 21 21 - Indifference
Staphylococcus aureus 30 27 11.1% Additivity

Antioxidant activity of the essential oil of Syzgium aromaticum.

Table 4 shows the antioxidant capacity of clove essential oil. The essential oil of Syzgium aromaticum had TAC value of 0.12mg/ml. However, reverse is the case in the Ferric Reducing Antioxidant Power (FRAP) values as the essential oil of Syzgium aromaticum had a higher value of 1.83mg/ml For Di-phenyl Picryl Hydrazyl Hydrate (DPPH) assay, the 1.13mg/ml was recorded for Syzgium aromaticum essential oil.

Table 4.

Antioxidant assay of essential oils

S/N ANTIOXIDANT ASSAY Syzgium aromaticum oil (mg/ml)
1. Di-phenyl Picryl Hydrazyl Hydrate (DPPH) (mg/ml) 1.13±0.65

2. Ferric Reducing Antioxidant Power (FRAP) (mgAAE/ml) 1.83±1.05

3. Total Antioxidant Capacity (TAC) (mg/ml) 0.12±0.07

Phytochemical screening of the essential oils

The phytochemical screening of the essential oil of Syzgium aromaticum, indicated the presence of several phytochemical compounds in the oils including; Flavonoids, Sterols, Phenols, Carbohydrates and Alkaloids. Table 5 shows the phytochemical screening results for the essential oils.

Table 5.

Phytochemical screening of the essential oils

Phytochemicals Tannin Saponin Terpenoids Flavonoids Glycosides Sterols Phlobatannns Phenols Carbohydrates Alkaloids Resins
Clove Essential oil - - - + - +++ - ++ + + -

Key: (-) Negative test; (+) Weak positive test; (++) Positive test; (+++) Strongly positive test.

Physicochemical analysis of the Essential oils

The result from Gas Chromatography-Mass Spectroscopy (GC-MS) analysis of the essential oil of Syzgium aromaticum, is as shown below. It can be depicted that clove essential oil has a total of 8 compounds which are represented as peaks in Figure 6.

Figure 6.

Figure 6

Graph showing peaks of components of Syzgium aromaticum essential oil.

Figure 7.

Figure 7

Molecular docking results of the various proteins of the bacteria isolated from samples and their corresponding performances when docked with compounds identified from CEO (after they passed the ADMET test and synthetic accessibilities verified)

Figure 8.

Figure 8

Image showing the interaction of eudesmol and the 4MCX of P. vulgaris.

Figure 9.

Figure 9

Image of the interaction of Eudesm-3-en-7-ol and the 4HBL of S. epidermidis.

Figure 10.

Figure 10

Image showing the interaction of Linalool and 7BYE of K.Pneumoniae

Discussion

A total of 7 bacterial species were isolated and it was observed that Proteus mirabilis indicated the highest percentage of occurrence after which Staphylococcus aureus and Pseudomonas aeruginosa which is similar to the findings of Ilechukwu et al., (2014), Ako-Nai et al., (2002) and Oni et al., (2001). However, these findings are in contrast with the trend in the developed world where non-typeable Heamophilus influenza, Streptococcus pyogenes and Moraxella catarrhalis assume important predominant roles in Otitis media (Casey et al., 2004).

Clove essential oil (CEO) showed inhibitory activity against all bacteria however moderate activity was observed in some. Similar antibacterial pattern of CEO against S. aureus was also reported in a study done by Abdullah et al., (2015). Thosar et al., (2013) also reported strong inhibitory effects of clove EO at low concentrations against all organisms tested as compared with other oils such as lavender and peppermint oil.

Haripriyan et al., (2018), studied the effect of clove bud oil on “four Pseudomonal proteases – elastase A, elastase B, Protease IV and alkaline protease” – each known to play a key role in Pseudomonal disease pathogenesis and it was established that clove bud oil exhibits “an immune-boosting property which supports its anti-virulence capacity and thus provides a two-pronged approach by which it inhibits P. aeruginosa infections”. Eugenol a major component of CEO has been proven effective in combating several pathogens such as S. typhyi, P. mirabilis (Devi et al., 2010; Devi et al., 2013), E. coli, S. aureus P. aeuriginosa (Walsh et al., 2003) by altering the integrity of their cell membranes (Devi et al., 2013), but according to the toxicity test conducted, it is not a suitable druggable compound. Hence, compounds from CEO such as linalool, cavacrol, eucalyptol, thymol, eudesmol and its gamma counterpart should be synthesized and clinically validated as potential new antimicrobial agents. Especially with regards to pediatric otitis media.

“The ability of plant extract to kill or eliminate microorganisms at the shortest period of time” is generally accepted definition of bactericidal activity in antibiotics (Pankey and Sabath, 2004). The results of Time kill kinetic studies of Clove EO against S. aureus and K. pneumoniae showed a steady decrease in cell population for both bacteria species with a continuous increase in time at intervals of 10 minutes. A 100% kill for Staphylococcus aureus was exhibited by CEO at a concentration of MIC x 2 at 70 min contact time while 100% kill of Klebsiella pneumoniae at a concentration of MIC x 1 within the shortest time of 70 min contact time was observed. The hydroxyl group OH of eugenol present in CEO contributes to its inhibitory effect as it binds to and affects the properties of proteins, thus inhibits the activity of some enzymes such as ATPases which may be important for cell kill at high eugenol concentrations because energy generation needed for cell recovery is impaired (Gill and Holley, 2006a).

Nucleotide leakage was observed in the cell wall of S. aureus and K. pneumoniae. This is indicating that there is a loss in purine and pyrimidine bases through a damaged cytoplasmic membrane (Stojkovic et al., 2013). When the test isolates were treated with clove essential oil, there was a continuous increase in rate of leakage as the exposure time increased. This is an indication of monophasic effects as described by Akinpelu et al. (2016). The nucleotides have strong UV absorption at 260 nm, membrane integrity can be determined through the detection of absorbance at this wavelength (Stojkovic et al., 2013). A steady increase in the leakage of protein content in the bacteria cells with increase in time exposure was also observed in this study. A study performed by Oyedemi et al., (2009) on a wide group of bacteria revealed that eugenol (a major component of clove EO) caused cell lysis by damaging the cell wall and membrane which led to the leakage of protein and lipid contents after 120 min of time exposure. Gill and Holley (2006b) also corroborated this findings.

CEO was observed to consist of 8 major compounds Eugenol (80.98%), Phenol, 2-methoxy-4-(2-propenyl)-, acetate (11.52%), Caryophyllene (6.00%), Humulene (0.81%), Caryophyllene oxide (0.22%), Phenol, 4-(2-propenyl) (0.22%), Methyl salicylate (0.16%) and 6-Methyl-2-Heptanol, acetate (0.10%). This is in consonance with the work of Omidbaigi et al., (2007) who reported eugenol, caryophyllene and eugenol acetate as the major components of CEO however while contrasting to the work of Naveed et al., (2013) who reported the presence of oxygenated monoterpenes and eucalyptol as the major component with eugenol in minor quantity. The variations in the chemical composition of the oil might have been due to the existence of different species and also the differences in agro-climatic conditions (Singh et al., 2008; Anwar et al., 2009; Singh et al., 2010; Lee, 2016).

Preliminary phytochemical analysis of the essential oils revealed the presence of flavonoids, sterols, phenols, carbohydrates and alkaloids in CEO. This was also reported by Dahiya and Soni, (2014), Ahmed, (2016) and Hemalatha et al., (2016). In contrast to this study, Oviya et al., (2016) reported the presence of tannin and glycosides. Phenols present in high contents have been found to denature proteins and react with cell membrane phospholipids changing their permeability (Briozzo et al., 1989). Peter and Wong (2006) opined that phytoconstituents obtained in the essential oil could account for its antioxidant and antimicrobial activity. Variations in phytochemical properties may be attributed to geographical conditions, climate, harvest season, period of distillation and extraction method used.

In silico analysis conducted in this study revealed that the components of the essential oils are potential lead molecules in the inhibition of bacterial growth and thus justify its use in traditional folklore medicine. It was observed that of the 36 phytocompounds identified by the GC-MS, only 16 of them passed the ADMET test. Also, out of these 16 compounds, their binding energy varies for each organism. In more specific terms: Linalool and cavacrol had best performance with S. aureus, g amma-eudesmol and eudesmol were top performer for P. mirabilis, S. epidermidis and P. aeruginosa. Eucalyptol, gamma-eudesmol and eudesmol for P. vulgaris. Finally, for Klebsiella pneumoniae Eudesm-3-en-7-ol and cavacrol methyl ether were the top performing phytocompounds. These compounds had the lowest binding energies, hence their potential to inhibit the synthesis of important proteins required by bacteria for survival. Their synthetic accessibilities were also put into consideration alongside the ADMET analysis. The ability of these phytocompounds (ligands) to bind to the active sites of enzymes, inhibits their substrates from binding, thereby interrupting the synthesis process of the proteins that play a key role in the survival or resistance mechanism of the bacteria. The lower the binding energy as compared to the binding energy of the normal substrate of an enzyme, the higher potential the phytocompound (ligand) possesses to interfere with synthesis.

Conclusion

Clove essential oil has long been known for its antibacterial potency and this study further confirms it. In silico study is a fast rising antimicrobial method that is proving to create more research options in the quest for alternatives to antibiotic therapy. Several advantages are associated with the use of spices as dietary supplement or alternative medicine including a reduction in the occurrences of antibiotic-resistant bacteria that results from the frequent use of antibiotics (misuse or abuse), a decrease in the cost of treatment and also minimal development of adverse drug reactions. This study reveals that the antibacterial potency of phytocompounds in essential oil is not dependent on its quantity therefore, all components of the oil should be treated and considered as potent until proven not to be. Further independent studies should be carried out on the phytocompounds with high binding energy identified from clove oil as alternative therapy in the treatment of Otitis media.

Conflict of Interest

The authors declare that there is no conflict of interest associated with this study.

List of Abbreviations:

OM –

Otitis Media;

EO –

Essential oil;

Eos –

Essential oils;

MIC –

Minimum Inhibitory Concentration;

MBC –

Minimum Bactericidal concentration.

References

  • 1.Abdullah B. H, Hatem S. F, Jumaa W. A Comparative Study of the Antibacterial Activity of Clove and Rosemary Essential Oils on Multidrug Resistant Bacteria. UK Journal of Pharmaceutical and Biosciences. 2015;3(1):18–22. [Google Scholar]
  • 2.Aduda D. S, Macharia I. M, Mugwe P, Oburra H, Farragher B, Brabin B, MacKenzie I. Bacteriology of chronic suppurative otitis media (CSOM) in children in Garissa district, Kenya:a point prevalence study. International Journal of Pediatric otorhinolarynology. 2013;77:1107–1111. doi: 10.1016/j.ijporl.2013.04.011. [DOI] [PubMed] [Google Scholar]
  • 3.Adukwu E. C, Allen S. C, Phillips C. A. The anti-biofilm activity of lemongrass (Cymbopogon flexuosus) and grapefruit (Citrus paradisi) essential oils against five strains of Staphylococcus aureus. Journal of Applied Microbiology. 2012;113(5):1217–1227. doi: 10.1111/j.1365-2672.2012.05418.x. [DOI] [PubMed] [Google Scholar]
  • 4.Ahmed W. Monitoring antioxidant and antityrosinase activity of clove aromatic flower buds. Journal of Medicinal Plants Studies. (2016);4(2):163–169. [Google Scholar]
  • 5.Ajayi i. A, Jonathan S. G, Adewuyi A, Oderinde R. A. Antimicrobial screening of essential oil of some herbal plants from Western Nigeria. World Appied Sciences Journal. 2008;3(1):79–81. [Google Scholar]
  • 6.Akinpelu D. A, Onakoya T. M. Antimicrobial activities of medicinal plants used in folklore remedies in south-western Nigeria. African Journal of Biotechnology. 2006;5(11):1078–1081. [Google Scholar]
  • 7.Akinpelu D. A, Odewade J. O, Aiyegoro O. A, Ashafa O. T, Akinpelu O. F, Agunbiade M. O. Biocidal effects of stem bark extract of Chrysophyllum albidium G. Don on vacomycin-resistant Staphylococcus aureus. BMC Complementary and Alternative Medicine. 2016:16–105. doi: 10.1186/s12906-016-1080-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ako-Nai A. K, Oluga F. A, Onipede A. O, Adejuyigbe E. A, Amusa Y. B. The characterization of bacterial isolates from acute otiti media in Ile-Ife, Southwestern Nigeria. Journal Tropical Pediatrics. 2002;48:15–23. doi: 10.1093/tropej/48.1.15. [DOI] [PubMed] [Google Scholar]
  • 9.Amel Ali Sulieman, Fadwa Mutaseim Eltayeb, Smah Ahmed Sulieman, and Nazar Abdalazeem Osman. Antimicrobial Activity of Zingiber officinale (Ginger) Oil against Bacteria Isolated from Children Throat International journal of microbiology. (2015);1:1–6. [Google Scholar]
  • 10.Anwar F, Ali M, Hussain A. I, Shahid M. Antioxidant and antimicrobial activities of essential oil and extracts of fennel (Foeniculum vulgare Mill.) seeds from Pakistan. Flavour and Fragrance Journal. 2009;24(4):170–176. [Google Scholar]
  • 11.Arroll B. Antibiotics for upper respiratory tract infections:An Overview of Cochrane Reviews. Respiratory Medicine. (2005);99(3):255–261. doi: 10.1016/j.rmed.2004.11.004. [DOI] [PubMed] [Google Scholar]
  • 12.Bakkali F, Averbeck S, Aberbeck D, Idaomar L. Biological effects of essential oils - A review. Food and Chemical Toxicology. 2008;46(2):446–475. doi: 10.1016/j.fct.2007.09.106. [DOI] [PubMed] [Google Scholar]
  • 13.Benzie I. F, Strain J. J. Ferric reducing/antioxidant power assay:direct measure o total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods of Enzymology. 1999;299:15–27. doi: 10.1016/s0076-6879(99)99005-5. [DOI] [PubMed] [Google Scholar]
  • 14.Blois M. S. Antioxidant determinations by the use of a stable free radical. Nature. (1958);181:1199–1200. [Google Scholar]
  • 15.Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. (1976);72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  • 16.Brand-Williams W, Cuvelier M. E, Berset C. Use of free radical method to evaluate antioxidant activity. Food and Science Technology. 1995;28:25–30. [Google Scholar]
  • 17.Briozzo J. Antimicrobial activity of clove oil dispersed in a concentrated sugar solution. Journal of Applied Bacteriology. (1989):66–6975. doi: 10.1111/j.1365-2672.1989.tb02456.x. [DOI] [PubMed] [Google Scholar]
  • 18.Casey J. R, Pichichero M. E. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Infectious Diseases Journal. 2004;23(9):824–828. doi: 10.1097/01.inf.0000136871.51792.19. [DOI] [PubMed] [Google Scholar]
  • 19.Chaieb K., H, Hajlaoui T, Zmantar K.A.B, Nakbi M, Rouabhia K, Mahdouani Bakhrouf A. The chemical composition and biological activity of essential oil, Eugenia cryophyllata (Syzygium aromaticum L Myrtaceae):a short review. Phytotherapy Research. (2007a);21(6):501–506. doi: 10.1002/ptr.2124. [DOI] [PubMed] [Google Scholar]
  • 20.Clinical and Laboratory Standards Institute (CLSI) 1. Vol. 30. National Committee for Clinical Laboratory Standards, Wayne,; USA: (2010). “Performance standard for antimicrobial susceptibility testing,”presented at the Approved Standard M100-S20. [Google Scholar]
  • 21.Cripps A, Kyd J. Bacterial otitis media:current vaccine development strategies. Immunology and Cell Biology. (2003);81(1):46–51. doi: 10.1046/j.0818-9641.2002.01141.x. [DOI] [PubMed] [Google Scholar]
  • 22.Dahiya P, Soni A. Phytochemical analysis, antioxidant and antimicrobial activity of Syzygium caryophyllatum essential oil. Asian Journal of Pharmaceutical and Clinical Research. 2014;7(2):202–205. [Google Scholar]
  • 23.Devi K. P, Sakthviel R, Nisha S. A, Suganthy N, Pandian S. K. Eugenol alters the integrity of cell membrane and acts against the nosocomial pathogen Proteus mirabilis. Archives in Pharm arceutical Research. 2013;36:282–292. doi: 10.1007/s12272-013-0028-3. [DOI] [PubMed] [Google Scholar]
  • 24.Dickson G. Acute Otitis media. Primary Care. (2014);41:11–18. doi: 10.1016/j.pop.2013.10.002. [DOI] [PubMed] [Google Scholar]
  • 25.Dorman H. J, Deans S. G. Antimicrobial agents from plants:antibacterial activity of plant volatile oils. Journal of Applied Microbiology. 2000;88(2):308–316. doi: 10.1046/j.1365-2672.2000.00969.x. [DOI] [PubMed] [Google Scholar]
  • 26.Egbe C, Mordi R, Omoregie R, Enabulele O. Prevalence of Otitis Media in Okada Community, Edo State, Nigeria. Macedonian Journal of Medical Science. 2010;3(3):299–302. [Google Scholar]
  • 27.Fu Y, Zu Y, Chen L, Shi X, Wang Z, Sun S. Antimicrobial activity of clove and rosemary essential oils alone and in combination. Phytotherapy Research. 2007;21(10):989–994. doi: 10.1002/ptr.2179. [DOI] [PubMed] [Google Scholar]
  • 28.Gill A. O, Holley R. A. Disruption of E. coli, Listeria monocytogenes and Lactobacillus sakei cellular membranes by plant oil aromatics. Applied Environmental Microbiology. (2006a);70:5750–5755. doi: 10.1016/j.ijfoodmicro.2005.10.009. [DOI] [PubMed] [Google Scholar]
  • 29.Gill A. O, Holley R. A. Inhibition of membrane bound ATPases of E. coli and Listeria monocytogenes by plant oil aromatics. International Journal of Food Microbiology. (2006b);111:170–174. doi: 10.1016/j.ijfoodmicro.2006.04.046. [DOI] [PubMed] [Google Scholar]
  • 30.Gupta C, Garg A. P, Uniyal R. C, Kumari A. Antimicrobial acivity of some herba oila against common food-borne pathogens. African Journal of Microbiology. 2008;2:258–261. [Google Scholar]
  • 31.Haripriyan J, Omanakuttan A, Menon N. D, Vanuopadath M, Nair S. S, Corriden R, Bipin G. N, Nizet V, Geetha B. K. Clove bud oil modulates pathogenicity phenotypes of the opportunistic human pathogen Pseudomonas aeruginosa. Scientific reports. 2018:8–3437. doi: 10.1038/s41598-018-19771-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hemalatha R, Nivetha P, Mohanapriya C.G, Sharmila C, Muthukumaran C, Gopinath M. Phytochemical composition, GC-MS analysis, In vitro antioxidant and antibacterial potential of clove flower bud (Eugenia Caryophyllus) methanolic extract. Journal of Food and Science Technology. 2016;53(2):1189–1198. doi: 10.1007/s13197-015-2108-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ilechukwu C. G. A, Ubesie A. C, Ojinnaka C. N, Emechebe G. O, Iloh2 K. K. Otitis Media in Children:Review Article. Open Journal of Pediatrics. 2014;4:47–53. [Google Scholar]
  • 34.Kalaivani G, Vidhya A. Watermelon seeds extracts and fresh juice for preliminary in vitro phytochemical screening and its antimicrobial activity analysed by TLC-bioautography technique. International Journal of Advancements in Life Sciences. 2014;7:74–80. [Google Scholar]
  • 35.Kon K. V, Rai M. K. Plant essential oils and their constituents in coping with multidrug-resistant bacteria. Expert Reviews of Anti-Infective Therapy. 2012;10(7):775–790. doi: 10.1586/eri.12.57. [DOI] [PubMed] [Google Scholar]
  • 36.Lee Y. Cytotoxicity evaluation of essential oil and its components from Zingiber officinale Roscoe. Toxicological Research. (2016);32(3):225–230. doi: 10.5487/TR.2016.32.3.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Leonardo G. F, Glaucius O, Andricopulo A.D. From Medicinal Chemistry to Human Health:Current Approaches to Drug Discovery or Cancer and Neglected Tropical Diseases. An Acad Bras Cienc. (2018) doi: 10.1590/0001-3765201820170505. https://dx.doi.org/10.1590/0001-3765201820170505. [DOI] [PubMed] [Google Scholar]
  • 38.Lopez –Vallejo F, Giulianotti M.A, Houghten R.A, Medina –Franco J. L. Expanding the medicinally relevant chemical space with compound libraries. Drug Discov Today. 2012;17((13-14)):718–726. doi: 10.1016/j.drudis.2012.04.001. [DOI] [PubMed] [Google Scholar]
  • 39.Naveed R, Hussain I, Tawab A, Tariq M, Rahman M, Hameed S, Mahmood M. S, Siddique A. B, Iqbal M. Antimicrobial activity of the bioactive components of essential oils from Pakistani spices against Salmonella and other multi-drug resistant bacteria. Complementary and Altenative Medicine. 2013;18413:265–275. doi: 10.1186/1472-6882-13-265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Obuotor T. M, Kolawole A.O, Apalowo O. E, Akamo A.J. Metabolic profling, ADME pharmacokinetics, molecular docking studies and antibacterial potential of Phyllantus muellerianus leaves. Advances in Traditional Medicine. (2021) https://doi.org/10.1007/s13596-021-00611-5. [Google Scholar]
  • 41.Odenholt I, Lowdin E, Cars O. In-vitro pharmacodynamicsof telithromycin against respiratory tract pathogens. Antimicrobal Agents Chemotherapy. 2001;45:23–29. doi: 10.1128/AAC.45.1.23-29.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Okore V. C. Principles of Pharmaceutical Microbiology. (2ndedn) Ephrata Publishers; Nigeria: (2010). [Google Scholar]
  • 43.Omidbaigi R, Yahyazadeh M, Zare R, Taheri H. The in vitro action of essential oils on Aspergillus flavus. Journal of Essential Oil-Bearing Plants. 2007;10(1):46–52. [Google Scholar]
  • 44.Oni A. A, Bakare R. A, Nwaorgu O. G. B, Ogunkunle M. O, Toki R. A. Bacterial agents of discharging ears and antimicrobial sensitivity patterns in children in Ibadan, Nigeria. West African Journal Medicine. 2001;20:131. [PubMed] [Google Scholar]
  • 45.Oviya V. J, Vishnupriya V, Gayathri R. Comparative analysis of antioxidant and free radicals scavenging activity of lemongrass oil and lavender oil. Asian Journal of Pharmaceutical and Clinical Research. 2016;9:136–139. [Google Scholar]
  • 46.Oyedemi S. O, Okoh A. I, Mabinya L. V, Pirochenva G, Afolayan A. J. The proposed mechanism of bactericidal action of eugenol. Α-terpineol and γ-terpinene against Listeria monocytogenes, Sreptococcus pyogenes, Proteus vulgaris and Escherichia coli. African Journal of BiotechnologyI. 2009;8(7):1280–1286. [Google Scholar]
  • 47.Pankey A, Sabath L.D. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action on the treatment of Gram-positive bacterial infections. Clinical and Infectious Diseases. (2004);38(6):864–870. doi: 10.1086/381972. [DOI] [PubMed] [Google Scholar]
  • 48.Peter Y. Y, Wong D. D. Studies on the dual antioxidant and antibacterial properties of parsley (Petroselinum crispum) and cilantro (Coriandrum sativum) extracts. Food Chemistry. 2006;97:505–515. [Google Scholar]
  • 49.Phyllis B, James B. Prescription for Nutritional Healing. (3rd ed) 2000:94. Avery Publishing. [Google Scholar]
  • 50.Prakash R, Juyul D, Negi V, Pal S, Adekhandi S, Sharma M, Sharma N. Microbiology of chronic suppurative otitis media in tertiary care setup of Uttarakhand state. Indian Science Abstracts- International Journal of Medical Science. 2013;5:282–287. doi: 10.4103/1947-2714.110436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Prashar A, Locke I. C, Evans C. S. Cytotoxicity of Clove (Syzgium aromaticum) oil and its major components to human skin cells. Cell Proliferation. 2006;39:241–248. doi: 10.1111/j.1365-2184.2006.00384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex:Specific application to the determination of vitamin E. Analytical Biochemistry. 1999;269:337–341. doi: 10.1006/abio.1999.4019. [DOI] [PubMed] [Google Scholar]
  • 53.Qureishi A, Lee Y, Belfield K, Birchall J. P, Daniel M. Update on otitis media- prevention and treatment. Infection and Drug Resistance. 2014;7:15–24. doi: 10.2147/IDR.S39637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Rios J.L, Recio M.C. Medicinal plants and antimicrobial activity. Journal of Ethnopharmacology. 2005;100:80–84. doi: 10.1016/j.jep.2005.04.025. [DOI] [PubMed] [Google Scholar]
  • 55.Saeed S, Tariq P. In Vitro Antibacterial activity of Clove against Gram negative bacteria. Pakistan Journal of Botany. 2008;40(5):2157–2160. [Google Scholar]
  • 56.Sattar A. A, Alamgir A, Hussain Z, Sarfraz S, Nasir J, Badar A. Bacterial Spectrum and their sensitivity pattern in patients of chronic suppurative otitis media. Journal of the college of physicians and surgeons Pakistan. 2012;22:128–129. [PubMed] [Google Scholar]
  • 57.Sharma K, Aggarwal A, Khurana P. M. Comparison of bacteriology in bilaterally discharging eras in chronic suppurative otitis media. Indian Journal of Otolaryngol Head and Neck Surgery. 2010;62:153–157. doi: 10.1007/s12070-010-0021-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Sierra A, Lopes P, Zapata M. A, Vanegas B, Castrejon M. M, DeAntonio R. Non-typeable Haemophilus influenza and Streptococcus pneumonia as primary causes of acute otitis media in Colombian children:a prospective study. BioMed Central infectious diseases. 2011;11(4):1–11. doi: 10.1186/1471-2334-11-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Singh G, Kapoor I. S, Singh P, de Heluani C. S, de Lampasona M. P, Catalan C. A. Chemistry, antioxidant and antimicrobial investigations on essential oil and oleoresins of Zingiber officinale. Food Chemistry Toxicology. 2008;46(10):3295–302. doi: 10.1016/j.fct.2008.07.017. [DOI] [PubMed] [Google Scholar]
  • 60.Singh P. S. R, Prakash B, Kumar A, Singh S, Mishra P. K, Dubey N. K. Chemical profile, antifungal, antiaflatoxigenic and antioxidant activity of Citrus maxima and Citrus sinensis (L.) Osbeck essential oils and their cyclic monoterpene, DL-limonene. Food Chemistry and Toxicology. 2010;48:1734–1740. doi: 10.1016/j.fct.2010.04.001. [DOI] [PubMed] [Google Scholar]
  • 61.Stojkovic D. S, Zlukovic J, Sokovic M, Glamocija J, Ferreira C. F. R, Jankovic T, Maskimovic Z. Antibacterial activity of Veronica montana L extract and of protocatechuic acd incorporated in s food system. Food and Chemical Toxicology. 2013;55:209–213. doi: 10.1016/j.fct.2013.01.005. [DOI] [PubMed] [Google Scholar]
  • 62.Thosar N, Basak S, Bahadure R. N, Rajurkar M. Antimicrobial efficacy of five essential oils against oral pathogens:An in vitro study. European Journal of Dentistr. 2013;7:71–77. doi: 10.4103/1305-7456.119078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Tiwari B. K, Valdramidis V. P, O'Donnell C. P, Muthukumarappan K, Bourke P, Cullen P. J. Applicaton of natural antimicrobials for food preservation. Journal of Agriculture and Food Chemistry. 2009;67:5987–6000. doi: 10.1021/jf900668n. [DOI] [PubMed] [Google Scholar]
  • 64.Trongtokit Y, Rongsriyam Y, Komalamisra N, Apiwathnasorn C. Comparative repellency of 38 essential oils against mosquito bites. Phytotherapy Research. 2005;19(14):303–309. doi: 10.1002/ptr.1637. [DOI] [PubMed] [Google Scholar]
  • 65.Walsh S. E, Maillard J. Y, Russell A. D, Catrenich C. E, Charbonneau D. L, Bartolo R. G. Activity and mechanisms of action of selected biocidal agents on Gram-positive and Gram-negative bacteria. Journal of Applied Microbilogy. 2003;94:240–247. doi: 10.1046/j.1365-2672.2003.01825.x. [DOI] [PubMed] [Google Scholar]
  • 66.Westh H, Zinn C. S, Rosdahl V. T Sarisa Study Group. An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries. Microbial Drug Resistance. 2004;10:169–176. doi: 10.1089/1076629041310019. [DOI] [PubMed] [Google Scholar]

Articles from African Journal of Infectious Diseases are provided here courtesy of African Traditional Herbal Medicine Supporters Initiative

RESOURCES